Viewing nowCombinationTelostop Plus Tablets 40/5/5 Milligrams
Telmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.

MFDS item code 201801975 · Approved 2018.05.10 · Insurance code 642906010
Treatment of hypertension, improvement of dyslipidemia, and inhibition of atherosclerotic progression and cardiovascular disease risk
This medication is used for patients with hypertension who have difficulty controlling blood pressure with the combined use of telmisartan and amlodipine alone. Additionally, rosuvastatin serves as an adjunct to dietary therapy for patients with hypercholesterolemia, helping to lower total cholesterol and LDL cholesterol levels, thereby delaying the progression of atherosclerosis and reducing the risk of cardiovascular disease. It is particularly effective in reducing the risk of stroke and myocardial infarction in high-risk groups such as men over 50 years and women over 60 years. Therefore, this medication improves the condition of patients requiring control over blood pressure and cholesterol levels.
This medicine should be taken once daily as 1 tablet with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking a telmisartan/amlodipine combination and rosuvastatin as separate medicines, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of the day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased to a maximum of 20 mg once daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of rosuvastatin 40 mg is contraindicated in some of these patients. In a drug interaction study of the active ingredients of this medicine, telmisartan/amlodipine 80/10mg and rosuvastatin 20mg, in the presence of telmisartan/amlodipine, rosuvastatin Cmax increased approximately 2.4-fold and AUC increased approximately 1.3-fold. Therefore, when administering this medicine, assess the potential risk associated with the increase in rosuvastatin Cmax and monitor the patient closely.
This medication can cause serious harm to the fetus and newborns if administered to pregnant women, thus it must be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with hypersensitivity to any component, or those with certain diseases, especially in cases of severe liver impairment, renal impairment, or specific heart conditions. Elderly patients, patients with impaired liver function, and those with hyperkalemia may have an increased risk of side effects, so it should be used cautiously. During treatment with this medication, if symptoms such as muscle pain, muscle weakness, or muscle cramps occur, patients should consult their healthcare provider immediately and blood tests should be performed to check for muscle damage if necessary. As there may be interactions with other medications, it’s essential to inform the healthcare provider about any medications currently being taken, with particular caution needed when combined with certain antibiotics, immunosuppressants, and antihypertensive agents. Since this medication can affect liver and kidney function, regular blood tests and liver function tests are recommended. Women of childbearing age should use appropriate contraception before taking this medication, and it is advised to avoid taking this medication while breastfeeding. In case of overdose, symptoms may include hypotension, arrhythmias, and impaired kidney function, requiring immediate medical attention. Patients should be cautious of dizziness or drowsiness when driving or operating dangerous machinery during treatment. The safety of this medication in children has not been sufficiently established, so it is not recommended for pediatric use. It should be stored out of reach of children and not transferred to other containers.
Viral upper respiratory infection, dyspnea, rectal bleeding, dyspepsia, atopic dermatitis, peripheral edema, chronic gastritis, various gastrointestinal disorders, hiatal hernia, infection, fungal infection, abscess, otitis media, headache, dizziness, orthostatic hypotension, low back pain, dizziness, headache, congestive heart failure, hepatocellular carcinoma, cerebral infarction, musculoskeletal pain, neck pain, nasopharyngitis, upper abdominal discomfort, upper abdominal pain, postural dizziness, dysuria, rhinitis, oral pharyngeal discomfort, lung disease, unspecified intestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory tract infection, low back pain, sinusitis, diarrhea, pharyngitis, influenza-like symptoms, dyspepsia, myalgia, urinary tract infection, abdominal pain, headache, dizziness, pain, fatigue, cough, hypertension, chest pain, nausea, erectile dysfunction, erectile dysfunction, increased sweating, flushing, allergy, fever, leg pain, lethargy, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, vertigo, sensory abnormalities, involuntary muscle contractions, rash, eczema, itching, angioedema, angioedema, erythema multiforme, itching, rash, erythematous rash, papular rash, frequent urination, urination disorder, nocturia, dry mouth, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, headache, dizziness, constipation, nausea, abdominal pain, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, weakness, angioedema, thrombocytopenia, liver dysfunction, acute renal failure, anemia, elevated CPK, anaphylactic reaction, tendon pain, headache, dizziness, weakness, cough, nausea, fatigue, frailty, edema, facial swelling, limb edema, angioedema, itching, hypersensitivity, increased sweating, erythema, chest pain, atrial fibrillation, congestive heart failure, myocardial infarction, elevated blood pressure, worsening hypertension, hypotension, hyperkalemia, hypoglycemia, syncope, dyspepsia, diarrhea, pain, urinary tract infection, low back pain, abdominal pain, muscle cramps, myalgia, bradycardia, eosinophilia, thrombocytopenia, increased uric acid, liver dysfunction, liver disease, thrombocytopenia, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, angioedema, polyneuropathy, memory loss, peripheral neuropathy, angioedema, angioedema, thrombocytopenia, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a tightly sealed container that blocks light. The storage temperature should ideally be maintained between 1 degree and 30 degrees Celsius at room temperature.
Pink oval film-coated tablet
30 tablets (10 tablets x 3)/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
DaeWon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.